慢性阻塞性肺疾病新指南对临床患者分类的应用价值

doi:10.6040/j.issn.1671-7554.0.2015.483

Abstract

Abstract: Objective To investigate the clinical significance of the clinical classification of the Spanish new clinical guidelines in chronic obstructive pulmonary disease(COPD)in 2013. Methods A total of 640 cases who had been diagnosed as COPD and hospitalized in the department of respiratory medicine of Anqing Municipal Hospital Affilicated to Anhui Medical University were collected from January 2009 to December 2014. According to the typing method of Spanish guidelines in 2013, the 640 cases were divided into four groups named A, B, C and D respectively. The pulmonary function, index of analysis of blood gas, morbidity of complication, the usage of antibiotics and hormone of each group were analyzed and compared. Results Pulmonary function forced expiratory volume in one second(FEV1)and forced expiratory volume in one second/forced vital capacity(FEV1%)in groups C and D were significantly lower than those in groups A and B(P<0.05). There was no significant difference in each group about the morbidity of diabetes and hypertension(P>0.05), while the incidence of coronary heart disease, arrhythmia and heart failure in groups C and D were significantly higher than those in groups A and B(P<0.05), and in group D higher than in group C(P<0.05). The usage time of antibiotics in groups A and B were significantly lower than that in groups C and D(P<0.05), and in group D was obviously higher than in group C(P<0.05). The use amount of hormone in group B was higher than that in groups A, C and D(P<0.05), and in groups C and D higher than in group A(P<0.05). In all groups, hospitalization time in group D was longest and shortest in group A. Usage of mechanical 山东大学学报 (医学版)54卷3期 -潘青,等.慢性阻塞性肺疾病新指南对临床患者分类的应用价值 \=-ventilation, mechanical ventilation time and mortality rate in group D was significantly higher than that in other groups(P<0.05). Conclusion The clinical classification of the new guidelines has important guiding role, but it needs further studies to verify its clinical value.

Key words: Spanish new clinical guidelines, Chronic obstructive pulmonary disease, Clinical classification

CLC Number:

R563

PAN Qing, LÜ Zhifang. Clinical application value of the new guide for patients with chronic obstructive pulmonary disease[J].JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(3): 63-67.

References

[1] Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary[J]. Am J Respir Crit Care Med, 2013, 187(4): 347-365.
[2] Davis KJ, Landis SH, Oh YM, et al. Continuing to Confront COPD International Physician Survey: physician knowledge and application of COPD management guidelines in 12 countries[J]. Int J Chron Obstruct Pulmon Dis, 2014, 10: 39-55.
[3] 金哲,王广发. 慢性阻塞性肺疾病全球倡议(2014更新版)解读[J].中国医学前沿杂志(电子版), 2014, 6(2): 94-97.
[4] 李仰瑞,熊伟,赵伟,等. 心血管合并症对老年慢性阻塞性肺疾病患者急性加重及预后的影响[J].老年医学与保健, 2014, 20(6): 400-405. LI Yangrui, XIONG Wei, ZHAO Wei, et al. The influence of cardiovascular complications on acute exacerbation and prognosis of chronic obstructive pulmonary disease in elderly patients[J]. Geriatr Health Care, 2014, 20(6): 400-405.
[5] Calverley PM, Anderson JA, Celli B, et al. Cardiovascular events in patients with COPD: TORCH study results[J]. Thorax, 2010, 65(8):719-725.
[6] 孙奥松,单守勤. CT冠状动脉成像与钙化积分结合评价冠心病的价值[J].实用放射学杂志, 2014, 30(3): 425-429. SUN Aosong, SHAN Shouqin. The value of hybrid CT coronary angiography and calcium score to assess coronary artery disease[J]. J Pract Radiol, 2014, 30(3): 425-429.
[7] Beran D, Zar HJ, Perrin C, et al. Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries[J]. Lancet Respir Med, 2015, 3(2): 159-170.
[8] Miravitlles M, Soler-Cataluña JJ, Calle M, et al. A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines(GesEPOC)[J]. Prim Care Respir J, 2013, 22(1): 117-121.
[9] Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD[J]. Am J Respir Crit Care Med, 2010, 182(5):598-604.
[10] Soriano JB, Davis KJ, Coleman B, et al. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom[J]. Chest, 2003, 124(2): 474-481.
[11] O’Hare PE, Ayres JF, O’Rourke RL, et al. Coronary artery calcification on computed tomography correlates with mortality in chronic obstructive pulmonary disease[J]. J Comput Assist Tomogr, 2014, 38(5): 753-759.
[12] Williams MC, Murchison JT, Edwards LD, et al. Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality[J]. Thorax, 2014, 69(8): 718-723.
[13] Etminan M, Jafari S, Carleton B, et al. Beta-blocker use and COPD mortality: a systematic review and meta-analysis[J]. BMC Pulm Med, 2012, 12: 48.
[14] Puente-Maestu L, Calle M, Ortega-González A, et al. Multicentric study on the beta-blocker use and relation with exacerbations in COPD[J]. Respir Med, 2014, 108(5): 737-744.
[15] Kargin F, Takir HB, Salturk C, et al. The safety of beta-blocker use in chronic obstructive pulmonary disease patients with respiratory failure in the intensive care unit[J]. Multidiscip Respir Med, 2014, 9(1): 8.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Comments

Recommended 0

No Suggested Reading articles found!

Clinical application value of the new guide for patients with chronic obstructive pulmonary disease

PDF (PC)

Abstract

Cite this article

share this article

References

Related Articles 5

Metrics

Comments

Recommended 0

[1]	YU Xiaolin, ZHANG Jun, YANG Liu, ZHOU Lin, CUI Liangliang, ZHANG Ji. Epidemiological characteristics of COPD patients attacked by respiratory system diseases during the flu season in Jinan City [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 79-82.
[2]	WU Yan， HUI Fu-xin， ZHAO Yin-ying， FAN Xiao-dong, BIAN Tao. Effect of virus infections on T lymphocyte subsets in patients with chronic obstructive pulmonary disease [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(11): 117-.
[3]	. Expressions of PPARγand cytokine in the bronchial mucosa of patients with chronic obstructive pulmonary disease [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(12): 91-94.
[4]	. Clinical research of chronic obstructive pulmonary disease and insulin resistance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(11): 14-16.
[5]	HAN Yi-qun,XUE Yu-wen,LI Chuan-fen,CHE Bo. The association between genetic polymorphism of superroxide dismutase and chronic obstructive pulmonary diseases [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(9): 940-943.